The federal Food and Drug Administration has issued a warning about four chewable flea and tick medications, cautioning that the products could lead to neurological issues such as seizures. The FDA is working with manufacturers that use the class of drugs isoxazoline in their products to include a clearer warning on the label, and is telling pet owners who use Bravecto, Credelio, Nexgard or Simparica to talk to their veterinarian about whether it’s appropriate for their pet. Owners who want an alternative for flea and tick prevention also should consult their veterinarian. Bravecto, Nexgard and Simparica all were approved by the FDA and have been in use for about five years. Credelio recently won approval. The majority of pets treated with the products have suffered no problems, but some dogs and cats have had seizures, muscle tremors and ataxia, which is a loss of coordination, balance, motor function control and sometimes cognitive impairment. The neurological issues might be more common in animals with a history of seizures, but they also have occurred in animals with no such history. The FDA is not pulling the products off the market, saying they remain safe for most animals. The warning is intended to alert consumers to a possible risk. Owners who are concerned or seeking an alternative for flea and tick prevention should consult their veterinarian. A number of complaints have been made about the products, spawning Change.org petitions here and in other parts of the world, demanding they be banned. A number of Facebook pages also are dedicated to getting the word out about the risks, which those who have lost pets or who are watching them suffer with seizures and loss of motor skills consider too great. The FDA advisory also suggests contacting your veterinarian if your dog or cat is experiencing any affects from an isoxazoline product, and reporting any incidents to the manufacturers, which are required to report the information to the FDA, or by submitting a report directly to the FDA.<doc-sep>'Whoever Is Watching This, They're Going To Get A Thrill': Willy T. Ribbs, Paul Tracy, Ernie Francis Jr. Discuss Superstar Racing ExperienceThe Superstar Racing Experience inaugural season begins on June 12 at Stafford Speedway. 'Rugrats' Voice Actors E.G. Daily And Cheryl Chase Call New Animation Style 'Brilliant': 'Every Time They Would Show Us We Would Just Gasp''In the words of Chuckie Finster, "Looks like a giant step to me" as the 90's classic Rugrats returns with all-new episodes and a slick modern animation style on Paramount+. WATCH: Caroline D'Amore Discusses 'Surreal' MTV's 'The Hills: New Beginnings' Experience & Pizza Girl BusinessThe Los Angeles native discusses what it was like to join the cast of "The Hills: New Beginnings" and her new line of sauce. SEC Football: CBS Sports Announces 2021 Schedule Including Alabama At Florida On September 18The SEC on CBS kicks off on September 18 with an SEC Championship game rematch between the Crimson Tide and Gators. Mayweather Vs. Paul: Showtime Sports Announces Broadcast Team For June 6 EventThe network announced its plans for the broadcast of the pay-per-view exhibition bout between Floyd Mayweather Jr. and Logan Paul. The 74th Annual 'Tony Awards' And 'The Tony Awards Present: Broadway's Back!' Come To CBS September 26thCBS and Tony Award Productions will celebrate Broadway’s highly anticipated return to live theatre with a multiplatform event The Tony Awards Present: Broadway's Back! Sunday, September 26th (9:00-11:00 PM, ET/PT) broadcasting on CBS and available to stream live and on demand with Paramount+ or the CBS app.<doc-sep>
Dogs and cats treated with certain flea and tick products might be at an increased risk for neurologic events including seizures, the U.S. Food and Drug Administration said Thursday. Treatments in the isoxazoline class, which are intended to ward off flea and tick infestations, are affected by the alert. That class includes products such as Bravecto, Nexgard and Simparica. Affected products continue to be safe for most animals but have been associated with muscle tremors, ataxia, and seizures in some pets, the FDA says. The treatments will soon "include new label information to highlight neurologic events because these events were seen consistently across the isoxazoline class of products," the FDA says. Although most pets have not had adverse reactions with the treatments, some have had seizures without a prior history, the FDA said in a fact sheet for pet owners. The alert comes after routine data collection revealed that some pets given isoxazoline class treatments "have experienced adverse events," the FDA says. Sept. 13:Eating dogs and cats banned in U.S. in House-passed bill Sept. 6:How to relieve your dog's boredom The majority of the affected products are sold as flavored chews, NBC News reports. The labels of such products already include information about the risk of neurological side effects, the network reports. There are a number of different products available to pet owners for the control of fleas and ticks, the FDA says. The agency recommends owners consult with a veterinarian to determine the appropriate treatment for their pet. The FDA has published contact information for pet owners who wish to report a possible adverse event.